Literature DB >> 12570837

The 1,4-dihydropyridine nucleus: a pharmacophoric template part 1. Actions at ion channels.

David J Triggle1.   

Abstract

The 1,4-dihydropyridine nifedipine is a prototypical example of the group of calcium channel blockers that also includes a number of second and third generation agents. These drugs enjoy substantial therapeutic prominence for their cardiovascular actions, including hypertension and angina. These actions are exerted at a specific member of the voltage-gated calcium channel family -the L-type channel. However, it is increasingly clear that the 1,4-dihydropyridine structure is a pharmacophoric template or "privileged structure" that, when appropriately substituted, can exert potent and selective actions at a diverse set of membrane receptors, including ion channels, G protein-coupled receptors and enzymes. This review will summarize the actions of 1,4-dihydropyridines at these receptors and advance the case that the 4-phenyl-1,4-dihydropyridine structure is a particularly versatile drug template. Part I of the review will summarize actions at ion channels and part II will summarize actions at other receptor systems.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12570837     DOI: 10.2174/1389557033488141

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  8 in total

1.  Vasorelaxant Effect of a Newly Synthesized Dihydropyridine Ethyl Ester (DHPEE) on Rat Thoracic Aorta: Dual Mechanism of Action.

Authors:  Hossein Babaei; Farzaneh Ebrahimi; Javid Shahbazi Mojarrad; Yadollah Azarmi; Afsaneh Gharehbagheri
Journal:  Adv Pharm Bull       Date:  2011-07-20

2.  Antileishmanial activity and ultrastructural alterations of Leishmania (L.) chagasi treated with the calcium channel blocker nimodipine.

Authors:  André Gustavo Tempone; Noemi Nosomi Taniwaki; Juliana Quero Reimão
Journal:  Parasitol Res       Date:  2009-04-08       Impact factor: 2.289

Review 3.  1,4-Dihydropyridines as calcium channel ligands and privileged structures.

Authors:  David J Triggle
Journal:  Cell Mol Neurobiol       Date:  2003-06       Impact factor: 5.046

4.  Synthesis and Vasorelaxant Effect of 9-aryl-1,8-acridinediones asPotassium Channel Openers in Isolated Rat Aorta.

Authors:  Mohsen Imenshahidi; Farzin Hadizadeh; Asieh Firoozeh-Moghadam; Mahmoud Seifi; Atefeh Shirinbak; Mohammad Bagher Gharedaghi
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

5.  Antihypertensive effects of new dihydropyridine derivatives on phenylephrine-raised blood pressure in rats.

Authors:  Sara Rowghani Haghighi Fard; Ramin Miri; Ali Akbar Nekooeian
Journal:  Res Pharm Sci       Date:  2016-12

6.  Evaluation of Physicochemical Properties of Amphiphilic 1,4-Dihydropyridines and Preparation of Magnetoliposomes.

Authors:  Oksana Petrichenko; Aiva Plotniece; Karlis Pajuste; Martins Rucins; Pavels Dimitrijevs; Arkadij Sobolev; Einars Sprugis; Andrejs Cēbers
Journal:  Nanomaterials (Basel)       Date:  2021-02-27       Impact factor: 5.076

7.  Ethyl 2,7,7-trimethyl-4-(1-methyl-1H-indol-3-yl)-5-oxo-1,4,5,6,7,8-hexa-hydro-quinoline-3-carboxyl-ate.

Authors:  Sema Oztürk Yildirim; Ray J Butcher; Miyase Gözde Gündüz; Ahmed El-Khouly; Rahime Simşek; Cihat Safak
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-12-08

8.  Ethyl 4-(5-bromo-1H-indol-3-yl)-2,6,6-trimethyl-5-oxo-1,4,5,6,7,8-hexa-hydro-quinoline-3-carboxyl-ate.

Authors:  Miyase Gözde Gündüz; Ray J Butcher; Sema Oztürk Yildirim; Ahmed El-Khouly; Cihat Safak; Rahime Simşek
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-11-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.